Saturday, 19 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14435
Articles
Drug
CDE Releases Guidelines for Chemically Synthesized Peptide Research
January 18, 2025
Company
Drug
Junshi Biosciences’ PD-1 Inhibitor Tuoyi Shows Promise in Phase III TNBC Study
January 18, 2025
Company
Deals
Abbott Partners with Sinopharm for Expanded Medical Solutions in China
January 18, 2025
Company
Drug
Luoxin’s Tegoprazan Gains NMPA Review for Duodenal Ulcer Treatment
January 18, 2025
Company
Drug
Shanghai Pharmaceuticals’ X842 Accepted for NMPA Review for Reflux Esophagitis
January 18, 2025
Company
Deals
We-Linking Raises Tens of Millions in Angel Round for Brain-Computer Interface
January 18, 2025
Company
Deals
Hybio Pharma and CR Medicine Collaborate on Market Expansion
January 18, 2025
Company
Drug
Junshi Biosciences Seeks UK MHRA Approval for PD-1 Inhibitor Tuoyi
January 18, 2025
Company
Drug
Chinagene Tech Initiates ZVS101e Gene Therapy Trial for Bietti’s Crystalline Dystrophy
January 18, 2025
Company
Drug
Ascletis Pharma’s ASC10 Shows Promising Phase I Results at CROI 2023
January 18, 2025
Company
Deals
Beijing Huashen Shengdian Secures Angel Funding for Pelvic Surgery Monitor R&D
January 18, 2025
Company
Drug
Zhaoke’s Generic Bimatoprost + Timolol Maleate Eye Drops Approved in China
January 18, 2025
1
2
…
1,027
1,028
1,029
1,030
1,031
…
1,202
1,203
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?